APL2
APL2-FSG-319
Phase 3 small_molecule active
Quick answer
APL2 for FSGS is a Phase 3 program (small_molecule) at Apellis Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Apellis Pharmaceuticals
- Indication
- FSGS
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active